{"generic":"Lodoxamide Tromethamine","drugs":["Alomide","Lodoxamide Tromethamine"],"mono":{"0":{"id":"jrkds0","title":"Generic Names","mono":"Lodoxamide Tromethamine"},"1":{"id":"jrkds1","title":"Dosing and Indications","sub":{"0":{"id":"jrkds1b4","title":"Adult Dosing","mono":"<ul><li><b>Keratitis, Vernal:<\/b> 1 to 2 drops 4 times\/day in affected eye(s) for up to 3 months<\/li><li><b>Vernal conjunctivitis:<\/b> 1 to 2 drops 4 times\/day in affected eye(s) for up to 3 months<\/li><li><b>Vernal keratoconjunctivitis:<\/b> 1 to 2 drops 4 times\/day in affected eye(s) for up to 3 months<\/li><\/ul>"},"1":{"id":"jrkds1b5","title":"Pediatric Dosing","mono":"<ul><li><b>Keratitis, Vernal:<\/b> age 2 yr and older, 1 to 2 drops 4 times\/day in affected eye(s) for up to 3 months<\/li><li><b>Vernal conjunctivitis:<\/b> age 2 yr and older, 1 to 2 drops 4 times\/day in affected eye(s) for up to 3 months<\/li><li><b>Vernal keratoconjunctivitis:<\/b> age 2 yr and older, 1 to 2 drops 4 times\/day in affected eye(s) for up to 3 months<\/li><\/ul>"},"3":{"id":"jrkds1b7","title":"Indications","mono":"<b>FDA-Labeled Indications<\/b><ul><li>Keratitis, Vernal<\/li><li>Vernal conjunctivitis<\/li><li>Vernal keratoconjunctivitis<\/li><\/ul>"}}},"3":{"id":"jrkds3","title":"Contraindications\/Warnings","sub":{"0":{"id":"jrkds3b9","title":"Contraindications","mono":"hypersensitivity to lodoxamide products<br\/>"},"2":{"id":"jrkds3b11","title":"Pregnancy Category","mono":"Lodoxamide: B (FDA)<br\/>"},"3":{"id":"jrkds3b12","title":"Breast Feeding","mono":"Lodoxamide: Micromedex: Infant risk cannot be ruled out.<br\/>"}}},"5":{"id":"jrkds5","title":"Adverse Effects","mono":"<b>Common<\/b><ul><li><b>Neurologic:<\/b>Headache<\/li><li><b>Ophthalmic:<\/b>Blurred vision, Burning sensation in eye, Dry eye, Itching of eye<\/li><li><b>Other:<\/b>Burning sensation<\/li><\/ul>"},"6":{"id":"jrkds6","title":"Drug Name Info","sub":{"0":{"id":"jrkds6b17","title":"US Trade Names","mono":"Alomide<br\/>"},"2":{"id":"jrkds6b19","title":"Class","mono":"<ul><li>Mast Cell Stabilizer<\/li><li>Ophthalmologic Agent<\/li><\/ul>"},"3":{"id":"jrkds6b20","title":"Regulatory Status","mono":"RX<br\/>"},"4":{"id":"jrkds6b21","title":"Generic Availability","mono":"No<br\/>"}}},"7":{"id":"jrkds7","title":"Mechanism Of Action","mono":"Lodoxamide tromethamine is a mast cell stabilizer that inhibits Type I immediate hypersensitivity reactions. Its definite mode of action is unknown, but it prevents the increase in cutaneous vascular permeability of calcium in relation with the reagin or IgE and antigen-mediated reactions.<br\/>"},"8":{"id":"jrkds8","title":"Pharmacokinetics","sub":{"3":{"id":"jrkds8b26","title":"Excretion","mono":"Renal <br\/>"},"4":{"id":"jrkds8b27","title":"Elimination Half Life","mono":"8.5 h <br\/>"}}},"9":{"id":"jrkds9","title":"Administration","mono":"<b>Ophthalmic<\/b><br\/>do not wear soft contact lenses while under treatment <br\/>"},"11":{"id":"jrkds11","title":"How Supplied","mono":"<b>Alomide<\/b><br\/>Ophthalmic Solution: 0.1 %<br\/>"},"13":{"id":"jrkds13","title":"Clinical Teaching","mono":"<ul><li>Patient should not wear soft contact lenses during treatment.<\/li><li>This drug may cause headache, blurred vision, dry eye, or an itching\/burning sensation in eye.<\/li><li>Instruct patient on proper instillation technique.<\/li><li>Patient should avoid concurrent use of other ophthalmic medications, unless approved by healthcare professional.<\/li><\/ul>"}}}